Why Altimmune, Inc.’s (ALT) Stock Is Down 5.56%
As of Wednesday, November 18, Altimmune, Inc.’s ALT share price has dipped by 5.56%, which has investors questioning if this is right time to buy.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | ALT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $258.8 | $203.5 | 32% |
|
| Shares Out (Mil) | 205.3 | 55.2 | 76% |
|
| Institutional Ownership | 99.2% | 93.3% | 85% |
|
| Float (Mil) | 174.3 | 40.4 | 71% |
|
| Beta | 0.15 | 1.05 | 10% |
|
| Avg Daily Volume (000s) | 5,068 | 569 | 92% |
|
| Price Change (52-week) |
(71.0%) | 38.8% | 13% |
|
| Growth | ALT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (12.4%) | (10.7%) | 27% |
|
| EPS (5yr) | 12.2% | 15.4% | 51 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (54.6%) | (15.7%) | 6% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | ($0.177) | ($0.627) | ($0.712) | |
| Month Ago EPS | ($0.160) | ($0.588) | ($0.668) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.160) | ($0.588) | ($0.668) | |
| Year/Year Chg | 14.9% | (37.3%) | (23.8%) | |
| Financials | ALT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $40 | na |
|
| Net Income (TTM) (Mil) | ($104) | ($44) | 11% |
|
| EPS (TTM) | ($0.671) | ($1.400) | 24% |
|
| Operating Cash Flow (TTM) (Mil) | ($102) | ($35) | 6% |
|
| Net Cash Flow (TTM) (Mil) | ($32) | $-0 | 24% |
|
| Long-Term Debt (Q1) (Mil) | $36 | $4 | 36% |
|
| Enterprise Value (Q1) (Mil) | $91 | $142 | 21% |
|
| Valuation | ALT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.58 | 1.96 | 15% |
|
| P/E | na | 16.9 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | ALT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.6% | na |
|
| Net Margin | na | (50.8%) | na |
|
| ROA | (29.2%) | (47.0%) | 16% |
|
| ROE | (33.2%) | (51.8%) | 19% |
|
| Liabilities to Assets | 10.5% | 29.6% | 6% |
|
| F-Score | 3 | 3 | 18% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.1% |
| +/- S&P 500: | -5.3 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors